165 related articles for article (PubMed ID: 37563361)
1. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.
Huang C; Xu R; Zhu X; Jiang H
Cancer Gene Ther; 2023 Oct; 30(10):1426-1440. PubMed ID: 37563361
[TBL] [Abstract][Full Text] [Related]
2. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
Ma XX; Cao ZG; Zhao SL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circABCC4 acts as a ceRNA of miR-154-5p to improve cell viability, migration and invasion of breast cancer cells in vitro.
Jiang J; Cheng X
Cell Cycle; 2020 Oct; 19(20):2653-2661. PubMed ID: 33023375
[TBL] [Abstract][Full Text] [Related]
4. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38822192
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression.
Huang C; Deng H; Wang Y; Jiang H; Xu R; Zhu X; Huang Z; Zhao X
J Cell Mol Med; 2019 Sep; 23(9):6112-6119. PubMed ID: 31270953
[TBL] [Abstract][Full Text] [Related]
6. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
7. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D
Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902
[TBL] [Abstract][Full Text] [Related]
8. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
9. m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
Wang X; Liu Y; Zhou M; Yu L; Si Z
J Exp Clin Cancer Res; 2023 Nov; 42(1):306. PubMed ID: 37986103
[TBL] [Abstract][Full Text] [Related]
10. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CCAR1, a Coactivator of β-Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells.
Chang TS; Wei KL; Lu CK; Chen YH; Cheng YT; Tung SY; Wu CS; Chiang MK
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230774
[TBL] [Abstract][Full Text] [Related]
12. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
13. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma.
Zhu YJ; Zheng B; Luo GJ; Ma XK; Lu XY; Lin XM; Yang S; Zhao Q; Wu T; Li ZX; Liu XL; Wu R; Liu JF; Ge Y; Yang L; Wang HY; Chen L
Theranostics; 2019; 9(12):3526-3540. PubMed ID: 31281495
[TBL] [Abstract][Full Text] [Related]
15. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
16. METTL3 regulates FAM83D m
Yu X; Li Y; Kong F; Xu Q
Toxicol In Vitro; 2024 Mar; 95():105746. PubMed ID: 38043628
[TBL] [Abstract][Full Text] [Related]
17. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
[TBL] [Abstract][Full Text] [Related]
18. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.
Zhang S; Lv C; Niu Y; Li C; Li X; Shang Y; Zhang Y; Zhang Y; Zhang Y; Zeng Y
Cell Death Dis; 2023 Feb; 14(2):91. PubMed ID: 36750551
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]